Search

everythinglearnresearchcommunity

for

Search:↓

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

The study suggests that hypothyroidism may cause alopecia areata.

Both treatments for alopecia areata showed similar modest effectiveness.

Individualized homeopathic treatment can effectively treat alopecia areata.

DPCP immunotherapy is effective for alopecia areata, and understanding influencing factors can improve treatment and satisfaction.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Combining calcipotriol and PRP is most effective for treating Alopecia Areata.

Trichoscopy is essential for diagnosing and managing alopecia areata in children.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Methotrexate and vitamin D3 are potentially more effective and safer than triamcinolone for treating localized alopecia areata.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

New treatments for child hair loss due to immune issues are effective but not yet officially approved.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.

Stress-related hair loss was reversed with a special medication.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.